Skip to content

Trial · Interventional

CompletedPhase 4Registry data

Early Follicular Supplementation of Ganirelix in IVF 2004

NCTNCT00461422 (opens ClinicalTrials.gov in a new tab)Other idsoltsman2004.CTIL
Open at ClinicalTrials.govAsk about this trial

Overview

Status
Completed
Phase
Phase 4
Enrollment
50 participants (actual)
Sponsor
The Baruch Padeh Medical Center, Poriya · Other gov
Design
Randomized · Open label (no masking)
Countries
1 country

Israel

Start
Jan 2004
Primary completion
Jun 2007
Completion
Jun 2007
First posted
18 Apr 2007 (estimated)
Last update posted
27 Jun 2008 (estimated)
Conditions
Infertility · IVF Treatment

Timeline

1 trial · 1 completed

  • Completed
  • Ongoing
  • Not yet recruiting
  • Stopped
  • Estimated dates (est.)
  • Results posted
20042005200620072008
  1. Ph 4

    Early Follicular Supplementation of Ganirelix in IVF 2004

    NCT00461422

    Jan 2004 to Jun 2007

Registry summary

Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.

Our goal was to investigate whether early follicular supplementation of the GnRH antagonist to the flexible GnRH antagonist protocol, has a potential to improve IVF-ET clinical results

Interventions

  • GanirelixDrug

Arms2

  • Experimental

    1

    Standard Flexible antagonist protocol Addition of Ganirelix at first 3 days of the cycle

  • No intervention

    2

    Standard Flexible antagonist protocol

Primary outcomes1

Outcomes the sponsor listed as primary.

  1. pregnancy rates

    Time frame · one cycle

Secondary outcomes(5)

  1. differences in hormonal levels

    Time frame · one cycle

  2. differences in the basic treatment doses

    Time frame · one cycle

  3. oocyte counts

    Time frame · one cycle

  4. fertilization rate

    Time frame · one cycle

  5. cleavage rate

    Time frame · one cycle

Posted results

Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.

No results are posted for this trial.

Completed trials do not always post results.

Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works

Studies0

Studies that cite this trial.

No study cites this trial.

Eligibility

Who could join, as posted.

Sex
Female
Age
Not stated
Healthy volunteers
Not accepted
Inclusion and exclusion criteria, as posted
Inclusion Criteria: * infertility * IVF candidate * failure of previous IVF attempt Exclusion Criteria: * low ovarian reserve * untreated distortion of uterine cavity * medical contraindication for IVF treatment

PepBank is a research reference. Talk to a doctor before you use any peptide.